Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

271.31 +6.38 (+2.41%)
Streaming Delayed Price Updated: 12:13 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bio-Rad Laboratories, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Bio-Rad Laboratories Inc. (NYSE: BIO) is a Leading Gainer in Wednesday Morning Trading
Via Investor Brand Network
News headline image
3 Beaten-Down Biotech Stocks Bound for a Bounce Back ↗
Biotech stocks are still below their post-pandemic peaks. But these beaten-down biotech stocks could lead the sector to new highs. 
Via InvestorPlace
News headline image
Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
The Latest Analyst Ratings for Bio-Rad Laboratories ↗
 
Via Benzinga
News headline image
Bio-Rad Reports Second-Quarter 2023 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
The Latest Analyst Ratings for Bio-Rad Laboratories ↗
 
Via Benzinga
News headline image
Death Cross Looms Over Bio-Rad Laboratories Investors ↗
 
Via Benzinga
News headline image
Recap: Bio-Rad Laboratories Q1 Earnings ↗
 
Via Benzinga
News headline image
Golden Cross Appears Before Bio-Rad Laboratories Investors ↗
 
Via Benzinga
News headline image
Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Why Are velo Biosciences Stock Is Trading Higher Today? ↗
Evelo Biosciences Inc (NASDAQ: EVLO) shares are trading higher after the company terminated its sublease agreement with Bio-Rad Laboratories Inc (NYSE: BIO). 
Via Benzinga
News headline image
Bio-Rad Announces New Share Repurchase Program
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Earnings Scheduled For February 16, 2023 ↗
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year... 
Via Benzinga
News headline image
Earnings Outlook For Bio-Rad Laboratories ↗
 
Via Benzinga
News headline image
Bio-Rad Publishes Corporate Sustainability Report for 2022
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023 ↗
 
Via Benzinga
News headline image
Bio-Rad to Present Company Overview at Jefferies Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Stocks Roar Back To Life; Still Pacing For Weekly Loss ↗
Rebounding bank stocks, stellar Apple earnings, and a blowout jobs report are all helping stocks move significantly higher Friday afternoon. 
Via Talk Markets
News headline image
Bio-Rad Reports First-Quarter 2023 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Bio-Rad to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
The 3 Most Promising Biotech Stocks to Buy Now ↗
With the NIH requesting its biggest budget yet, these are the three most promising healthcare stocks to buy now. 
Via InvestorPlace
News headline image
I Asked ChatGPT for 10 EV Stocks to Buy. Here’s What It Recommended. ↗
What are the best EV stocks to buy? ChatGPT has different answers, depending on how it is asked. Here's what investors need to know. 
Via InvestorPlace
News headline image
Bio-Rad to Participate in Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover ↗
Danaher is reportedly looking to add to its wheelhouse to compete with Thermo. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.